GLP1R and type 2 diabetes mellitus: Furthermore, one Swedish research claimed that only one-third of individuals with T2D who are suitable for treatment with SGLT2ins or GLP-1 Ras, according to EASD/ADA guidelines, have been prescribed these medications [29].